Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Share-based Compensation Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.69%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.57%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -4.08%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 12.94%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 26.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 59.09%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 31.63%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -45.45%
Jun 30, 2025 -33.33%
Mar 31, 2025 -15.78%
Dec 31, 2024 -10.45%
Sep 30, 2024 47.65%
Jun 30, 2024 173.35%
Mar 31, 2024 45.87%
Dec 31, 2023 46.79%
Sep 30, 2023 16.22%
Jun 30, 2023 -23.12%
Mar 31, 2023 0.65%
Dec 31, 2022 -9.75%
Sep 30, 2022 10.52%
Jun 30, 2022 22.80%
Mar 31, 2022 34.43%
Dec 31, 2021 97.77%
Sep 30, 2021 144.73%
Jun 30, 2021 111.36%
Mar 31, 2021 69.52%
Dec 31, 2020 38.22%
Sep 30, 2020 149.47%
Jun 30, 2020 464.10%
Mar 31, 2020 120.49%
Dec 31, 2019 34.90%
Sep 30, 2019 -31.16%
Mar 31, 2019 -66.48%
Dec 31, 2018 150.39%
Sep 30, 2018 -29.59%
Mar 31, 2018 58.26%
Sep 30, 2017 -59.11%
Jun 30, 2017 -48.05%
Mar 31, 2017 69.02%
Sep 30, 2016 7.86%
Jun 30, 2016 49.93%
Mar 31, 2016 -40.83%
Dec 31, 2015 -1,195.47%
Sep 30, 2015 64.63%
Jun 30, 2015 -38.15%
Mar 31, 2015 -28.63%
Dec 31, 2014 -100.41%
Sep 30, 2014 213.94%
Jun 30, 2014 67.01%
Mar 31, 2014 999.36%
Sep 30, 2013 65.98%
Jun 30, 2013 -60.10%
Mar 31, 2013 -94.35%
Sep 30, 2012 -167.76%
Jun 30, 2012 8,862.00%
Mar 31, 2012 -22.05%
Dec 31, 2011 -47.14%
Sep 30, 2011 17.93%